GlobeNewswire

Dahua Technology H.265 Wi-Fi Cameras A26/C26 Serves Consumer Market

Dela

HANGZHOU, China, Oct. 24, 2017 (GLOBE NEWSWIRE) -- To better serve consumer users, Dahua Technology, a leading solution provider in the global video surveillance industry, released its H.265 Consumer Series products earlier this year. It is now available to most of its markets globally. Below are the details about 2 selected cameras - the indoor cube model C26 and the Pan& Tilt model A26.

In an era when people are less and less at home, they are in urgent need of a way to stay connected to it. A26/C26 came along to solve the problem. C26 supports intelligent Human Detection and instant alert, keeping consumers aware of what is going on at home any time they want. Smart Tracking of A26/A46 automatically tracks and keeps tracking any moving object around the camera.

Feature Highlights:

Fluent High-resolution Video based upon H.265

With 2MP image sensor, A26/C26 delivers crystal clear image. The latest H.265 compression saves up to 50% bandwidth and storage, eliminating users' worry about the network bandwidth or storage while enjoying the better video.

Cloud Services through Easy4ip App

With an Easy4ip cloud account, you'll have access to your camera through your smart phone as long as Internet is available. You can record daily or motion videos on Easy4ip Cloud and playback anytime anywhere. Also, Dahua Easy4ip platform support IFTTT, which enables Dahua cameras to interact with other smart home applications, such as Philippe Hue, Amazon Alexa, etc.

Instant Alert via Motion Detection

With a home surveillance camera that support motion detection, you can rest assure that whenever motion event happens, the cameras will be triggered to send you a message about it.

24/7 Protection with Dahua Smart IR LED

With high quality IR LED and Dahua Smart IR algorithm the cameras automatically switches the night mode on and off, and they can adjust the brightness of the IR LED automatically when the light condition changes. So even in complete darkness you can see the video clearly.

Two-way Audio

Dahua Indoor Wi-Fi Cameras support built-in Mic and Speaker, so all the recorded motion or daily videos are with vivid audio, and they support Two-way Talk. When someone breaks in you'll receive an alarm alert at the real time, and remotely you can tell the unwelcome guy to "GET OUT". Also, you can communicate with your lovely child or pet while looking at them.

Special Specifications of Each Camera

A26

A26 supports 355° Pan &90° Tilt, so you can rotate it to see all directions with no blind points. Smart Tracking based upon advanced tracking algorithm enables the camera to automatically focus on and follow moving objects in both horizontal and vertical way, even when the camera is installed on the ceiling.

C26

C26, with super wide 130° horizontal field of view, enables you to see a whole room through 1 camera. And with the magnetic base you can stick it to any metal surface. With Human Detection based upon powerful image processing technology, C26 detects people by recognizing human heads, greatly reducing false alerts to situations such as falling leaves and light change.

Applications

Home

There are many occasions when people are away from home but want to keep in touch with the family. If you have a baby or a pet, you want more to talk to the family and see them. When the whole family is traveling, their empty apartments are left at risk of theft and burglary. Now with A26/C26, family communication and home safety will be considerably enhanced.

Shops

A shop is a place of many goods and people, which means there is a lot at stake. A26/C26 cameras enable shopkeepers to notice almost all situations through just 1 camera without many false alerts.

Dahua launched A26/C26 cameras to enhance the connection of people to their homes. With the latest H.265 compression, A26/C26 cameras deliver crystal clear image without users worrying about storage space and network bandwidth. And with Intelligent functions like Human Detection and Smart Tracking, Dahua keeps on making home safety much easier. With a mission of "Enabling a Safer Society and Smarter Living", Dahua will continue to focus on "Innovation, Quality, and Service", to serve partners and customers around the world.


About Dahua Technology

Zhejiang Dahua Technology Co., Ltd. is a leading solution provider in the global video surveillance industry. In 2016, Dahua was ranked 4th in  " Security Top 50 "  by a&s international. Dahua is committed to providing the highest quality solutions and products with the latest technologies to enable our end users to perform their business successfully. The company has more than 5,000 R&D engineers and technical staff working on cutting-edge technologies in camera lens, image sensor, video encoding & transmission, embedded processor, graphic processing, video analytics, software reliability, network security and other technologies.

Visit  http://www.dahuasecurity.com t o learn more and follow us on  Facebook  and  LinkedIn .

Media Contact

Vivid  Gu,

Senior Marketing Officer

( Gu_Jun1@dahuatech.com ) Tel:+86-571-28069750

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f062db34-f051-44c2-8470-02df5d0bf7b4

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/91997922-c066-4449-882b-0cd5f8d03f8b

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f977fed5-5dad-4216-9443-59396985ab26

Vivid Gu
Dahua Technology
gu_jun1@dahuatech.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Dahua Technology via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum